The Tiramisu Approach to
Treatment Resistant Depression:
Integrating Psychotherapy, Pharmacology,
CAM and Neurotherapeutics
DATE: Wednesday, May 8, 2019 1:00 p.m. ET, 12:00 p.m. CT, 10:00 a.m. PT, 11:00 a.m. MT
DURATION: 1 hour
Approximately a third of patients with major depressive disorder do not respond to treatment, with only half achieving remission. This results in high morbidity and makes MDD one of the leading causes of disability in the world per the World Health Organization. Early intervention, intensive and multimodal treatment are key to improving outcomes in this patient population. Challenges inherent to treatment include polymorphism in the presentation, multifactorial etiology and complex pathophysiology. In this presentation, we will review current evidence for approaching patients with difficult to treat presentations using psychotherapy, psycho-pharmacology, neurotherapeutics and complementary-alternative medicine. In addition, we will discuss the latest developments in conceptualizing treatment resistance and novel, experimental treatments that are under investigation.
As a result of this presentation, the participant should be able to:
Jasleen Chhatwal, MD
Associate Medical Director, Director of Mood Recovery
This course has been approved by NACCME, LLC, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #182840. NACCME is responsible for all aspects of the programing.
Utah Mental Health Counselors Association is Utah's hub for enhancing the profession of mental health counselors. UMHCA is a 501(c)6 organization.© 2019 UHMCA Policies • Privacy • Site Map